Analyst Ratings for Novartis (nvs)
nvs Rating Summary
nvs Price Target Summary
- Highest: $180.00 (TD Cowen)
- Lowest: $126.00 (CFRA)
- Average: $156.57
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$156.57 (+9.3%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
Avg. $ Target:
$156.57 (+9.3%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/10/2026 | HSBC | Rajesh Kumar | Upgrade | Hold (Reduce) |
136.00 (123.00) |
137.70 (143.28) |
4.05% | Details |
| 3/11/2026 | Argus | Jasper Hellweg | Upgrade | Buy (Hold) |
180.00 (N/A) |
161.59 (143.28) |
-11.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
